Have a personal or library account? Click to login
Epicardial Adipose Tissue – A New Biomarker of Cardiovascular Risk Cover

Epicardial Adipose Tissue – A New Biomarker of Cardiovascular Risk

By: Mircea Cinteză and  Imre Benedek  
Open Access
|Jun 2016

References

  1. 1. Nakanishi K, Fukuda S, Tanaka A, et al. Epicardial Adipose Tissue Accumulation Is Associated With Renal Dysfunction and Coronary Plaque Morphology on Multidetector Computed Tomography. Circ J. 2015;80:196-201. doi: 10.1253/circj.CJ-15-0477.10.1253/circj.CJ-15-047726497330
  2. 2. Maurovich-Horvat P, Kallianos K, Engel LC, et al. Relationship of thoracic fat depots with coronary atherosclerosis and circulating inflammatory biomarkers. Obesity. 2015;23:1178-1184. doi: 10.1002/oby.21080.10.1002/oby.21080444616025960369
  3. 3. Doesch C, Jochims J, Streitner F, et al. Novel prognostic markers derived from cardiovascular magnetic resonance imaging in patients with stable chronic coronary artery disease. InVivo. 2015;29:737-747.
  4. 4. Ridker PM. From C-reactive protein to interleukin-6 to Interleukin-1. Moving upstream to identify novel targets for atheroprotection. Circ Res. 2016;1:145-156. doi: 10.1161/ CIRCRESAHA.115.306656.10.1161/CIRCRESAHA.115.306656479371126837745
  5. 5. Gauss S, Klinghammer L, Steinhoff A, et al. Association of systemic inflammation with epicardial fat and coronary artery calcification. Inflamm Res. 2015;64:313-319. doi: 10.1007/ s00011-015-0809-x.10.1007/s00011-015-0809-x25763815
  6. 6. Hajsadeghi F, Nabavi V, Bhandari A, et al. Increased epicardial adipose tissue is associated with coronary artery disease and major adverse cardiovascular events. Atherosclerosis. 2014;237:486-489. doi: 10.1016/j.atherosclerosis.2014.09.037.10.1016/j.atherosclerosis.2014.09.03725463078
  7. 7. Bo X, Ma L, Fan J, et al. Epicardial fat volume is correlated with coronary lesion and its severity. Int J ClinExp Med. 2015;8:4328-4334.
  8. 8. Romijn MA, Danad I, Bakkum MJ, et al. Incremental diagnostic value of epicardial adipose tissue for the detection of functionally relevant coronary artery disease. Atherosclerosis. 2015;242:161-166. doi: 10.1016/j.atherosclerosis.2015.07.005.10.1016/j.atherosclerosis.2015.07.00526188540
  9. 9. Hell MM, Achenbach S, Schuhbaeck A, Klinghammer L, May MS, Marwan M. CT-based analysis of pericoronary adipose tissue density: Relation to cardiovascular risk factors and epicardial adipose tissue volume. J Cardiovasc Comput Tomogr. 2016;10:52-60. doi: 10.1016/j.jcct.2015.07.011.10.1016/j.jcct.2015.07.01126256553
  10. 10. Khawaja T, Greer C, Thadani SR, et al. Increased regional epicardial fat volume associated with reversible myocardial ischemia in patients with suspected coronary artery disease. J Nucl Cardiol. 2015;22:325-333. doi: 10.1007/s12350-014-0004-4.10.1007/s12350-014-0004-4447473325339129
  11. 11. Tanindi A, Erkan AF, Ekici B. Epicardial adipose tissue thickness can be used to predict major adverse cardiac events. Coron Artery Dis. 2015;26:686-691. doi: 10.1097/ MCA.0000000000000296.10.1097/MCA.000000000000029626267746
  12. 12. Chun H, Suh E, Byun AR, Park HR, Shim KW. Epicardial fat thickness is associated to type 2 diabetes mellitus in Korean men: a cross-sectional study. Cardiovasc Diabetol. 2015;14:46. doi: 10.1186/s12933-015-0210-7.10.1186/s12933-015-0210-7443251925935836
  13. 13. Opincariu D, Mester A, Dobra M, et al. Prognostic value of epicardial fat thickness as a marker of increased inflammatory status in patients with type 2 diabetes mellitus and acute myocardial infarction. J Cardiovasc Emerg. 2016;2(1):11-18. doi: 10.1515/jce-2016-0003.10.1515/jce-2016-0003
DOI: https://doi.org/10.1515/jce-2016-0001 | Journal eISSN: 2457-5518 | Journal ISSN: 2457-550X
Language: English
Page range: 4 - 6
Published on: Jun 3, 2016
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2016 Mircea Cinteză, Imre Benedek, published by Asociatia Transilvana de Terapie Transvasculara si Transplant KARDIOMED
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.